Treatment of advanced disease and new drugs

Suppl Tumori. 2003 Sep-Oct;2(5):S48-50.
No abstract available

Publication types

  • Review

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Camptothecin / analogs & derivatives*
  • Camptothecin / therapeutic use
  • Capecitabine
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Docetaxel
  • Enzyme Inhibitors / therapeutic use
  • Fluorouracil / therapeutic use
  • Humans
  • Irinotecan
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin
  • Paclitaxel / analogs & derivatives*
  • Paclitaxel / therapeutic use
  • Stomach Neoplasms / drug therapy*
  • Taxoids*
  • Topoisomerase I Inhibitors

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Enzyme Inhibitors
  • Organoplatinum Compounds
  • Taxoids
  • Topoisomerase I Inhibitors
  • Oxaliplatin
  • Deoxycytidine
  • Docetaxel
  • Capecitabine
  • Irinotecan
  • Paclitaxel
  • Fluorouracil
  • Camptothecin